Medical expenditures for cancer are projected to reach at least $158 billion in today’s dollars by 2020. That’s a 27 percent increase, assuming that incidence and treatment costs remain at 2010 levels, according to a National Institutes of Health (NIH) analysis of growth and aging of the U.S. population.
But new diagnostic tools and treatments could raise medical expenditures as high as $207 billion, assuming that the costs of new treatments increases 5 percent, said the researchers from the National Cancer Institute (NCI), part of the NIH. The analysis appears in the Journal of the National Cancer Institute. Recent trends reflect a 2 percent annual increase in medical costs in the initial and final phases of care, which would boost projected 2020 costs to $173 billion.Projections of expenses, assuming steady incidence and survival rates and no increase in treatment costs
Projections were based on the most recent data available on cancer incidence, survival and costs of care. In 2010, medical costs associated with cancer were projected to reach $127.6 billion, with the highest costs associated with breast cancer ($16.5 billion), followed by colorectal cancer ($14 billion), lymphoma ($12 billion), lung cancer ($12 billion) and prostate cancer ($12 billion). Read more »
*This blog post was originally published at ACP Internist*
Many conservatives are up-in-arms about President Obama’s decision to appoint Don Berwick, a pediatrician and renowned expert in quality improvement and patient safety, to lead the Center for Medicare and Medicaid Services (CMS). They object to Dr. Berwick’s views on a range of issues, and to Obama’s decision to use his office’s authority to appoint Dr. Berwick while the Senate was out on a short Independence Day holiday recess. As a “recess appointment,” Dr. Berwick was able to take office without Senate hearings and confirmation, but he can only serve through the end of the 111th Congress — that is, until the end of 2011 — unless ratified by the Senate.
Berwick, though, also has many supporters. Maggie Mahar articulates the “pro” viewpoint on Dr. Berwick’s appointment in a recent Health Beat post. She observes that two former CMS administrators who served in Republican administrations have commented positively about Dr. Berwick’s qualifications. Read more »
*This blog post was originally published at The ACP Advocate Blog by Bob Doherty*
Heart attack mortality fell by nearly a half a percent last year at 4,500 hospitals that treat Medicare patients. And, facilities with the lowest and highest death rates saw similar declines, according to a new hospital report card by the U.S. Centers for Medicare and Medicaid Services (CMS).
Heart attack mortality fell from a national average of 16.6 percent last year to 16.2 percent, with a range among all facilities from 14.5 percent to 17.9 percent. CMS released the data as part of its hospital report card effort to spur better quality and outcomes through public reporting of recommended treatments. The agency added heart attack and heart failure mortality to the report card three years ago.
At issue now is what’s driving the figures: public reporting of hospital data driving improvement, or faster door-to-balloon-treatment times. Areas that do need to improve include lowering readmissions and getting people to the hospital faster when they have a heart attack. (USA Today)
*This blog post was originally published at ACP Hospitalist*